Collate Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $95M

  • Investors
  • 6

Collate General Information

Description

Developer of an AI-based documentation platform designed to support life sciences product development workflows. The company's platform uses artificial intelligence to automate document creation, review, and management across research, clinical validation, quality assurance, and regulatory processes, enabling diagnostics, medical device, and pharmaceutical organizations to streamline compliance workflows, improve operational efficiency, and manage product lifecycle documentation from development to commercialization.

Contact Information

Website
www.collate.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500 Treat Avenue
  • San Francisco, CA 94110
  • United States
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 500 Treat Avenue
  • San Francisco, CA 94110
  • United States

Collate Timeline

2026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Collate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 03-Jun-2026 $95M Completed Generating Revenue
1. Seed Round 13-Jan-2025 Completed Generating Revenue
To view Collate’s complete valuation and funding history, request access »

Collate Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Seed
To view Collate’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Collate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Collate Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
CRV Venture Capital Minority
Conviction Partners Venture Capital Minority
First Round Capital Venture Capital Minority
Parcel B Venture Capital Minority
Redpoint Ventures Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Collate Acquisitions (1)

Collate’s most recent deal was a Merger/Acquisition with MantleBio. The deal was made on 12-Aug-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MantleBio 12-Aug-2025 Merger/Acquisition Business/Productivity Software
To view Collate’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Collate Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
MantleBio San Francisco, CA 2023

Collate FAQs

  • When was Collate founded?

    Collate was founded in 2025.

  • Where is Collate headquartered?

    Collate is headquartered in San Francisco, CA.

  • What is the size of Collate?

    Collate has 8 total employees.

  • What industry is Collate in?

    Collate’s primary industry is Enterprise Systems (Healthcare).

  • Is Collate a private or public company?

    Collate is a Private company.

  • What is the current valuation of Collate?

    The current valuation of Collate is .

  • What is Collate’s current revenue?

    The current revenue for Collate is .

  • How much funding has Collate raised over time?

    Collate has raised $125M.

  • Who are Collate’s investors?

    CRV, Conviction Partners, First Round Capital, Parcel B, and Redpoint Ventures are 5 of 6 investors who have invested in Collate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process